Guidelines for the management of hydrocephalus associated with aSAH: Difference between revisions
(Created page with "__NOTOC__ {{Subarachnoid hemorrhage}} {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{SaraM}} ==2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage...") |
No edit summary |
||
Line 5: | Line 5: | ||
====== | ===Management of Hydrocephalus Associated With aSAH: Recommendations=== | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' aSAH-associated acute symptomatic hydrocephalus should be managed by cerebrospinal fluid diversion (EVD or lumbar drainage, depending on the clinical scenario) ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' aSAH-associated chronic symptomatic hydrocepha- lus should be treated with permanent cerebrospinal fluid diversion ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|} | |} | ||
{|class="wikitable" | {|class="wikitable" | ||
Line 18: | Line 18: | ||
|colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm) | |colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm) | ||
|- | |- | ||
|bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' Weaning EVD over >24 hours does not appear to be effective in reducing the need for ventricular shunting ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|- | |- | ||
|bgcolor=" | |bgcolor="LightCoral"|<nowiki>"</nowiki>'''2.''' Routine fenestration of the lamina terminalis is not useful for reducing the rate of shunt-dependent hydrocephalus and therefore should not be routinely performed. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|} | |} | ||
Latest revision as of 00:56, 22 November 2016
Subarachnoid Hemorrhage Microchapters |
Diagnosis |
---|
Treatment |
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012)
|
Case Studies |
Guidelines for the management of hydrocephalus associated with aSAH On the Web |
American Roentgen Ray Society Images of Guidelines for the management of hydrocephalus associated with aSAH |
FDA on Guidelines for the management of hydrocephalus associated with aSAH |
CDC on Guidelines for the management of hydrocephalus associated with aSAH |
Guidelines for the management of hydrocephalus associated with aSAH in the news |
Blogs on Guidelines for the management of hydrocephalus associated with aSAH |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Mehrsefat, M.D. [2]
2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage[1]
Management of Hydrocephalus Associated With aSAH: Recommendations
Class I |
"1. aSAH-associated acute symptomatic hydrocephalus should be managed by cerebrospinal fluid diversion (EVD or lumbar drainage, depending on the clinical scenario) (Level of Evidence: B)" |
"2. aSAH-associated chronic symptomatic hydrocepha- lus should be treated with permanent cerebrospinal fluid diversion (Level of Evidence: C)" |
Class III (Harm) |
"1. Weaning EVD over >24 hours does not appear to be effective in reducing the need for ventricular shunting (Level of Evidence: B)" |
"2. Routine fenestration of the lamina terminalis is not useful for reducing the rate of shunt-dependent hydrocephalus and therefore should not be routinely performed. (Level of Evidence: B)" |
References
- ↑ Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage http://stroke.ahajournals.org/content/early/2012/05/03/STR.0b013e3182587839